These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Salivary production in Parkinson's disease. Proulx M; de Courval FP; Wiseman MA; Panisset M Mov Disord; 2005 Feb; 20(2):204-7. PubMed ID: 15389996 [TBL] [Abstract][Full Text] [Related]
4. [Sudomotor dysfunction in Parkinson's disease]. Yoshioka M; Oka H; Morita M; Inoue K Rinsho Shinkeigaku; 2003 Jul; 43(7):379-84. PubMed ID: 14582362 [TBL] [Abstract][Full Text] [Related]
5. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251 [TBL] [Abstract][Full Text] [Related]
6. Sympathetic sudomotor and vasoconstrictive neural function in patients with Parkinson's disease. Shindo K; Iida H; Watanabe H; Ohta E; Nagasaka T; Shiozawa Z Parkinsonism Relat Disord; 2008 Nov; 14(7):548-52. PubMed ID: 18321756 [TBL] [Abstract][Full Text] [Related]
7. [Kinetic assessment of salivary secretory response to citric acid. Differences with pilocarpine]. Durán V; Domínguez P; Morales I; López RO Rev Med Chil; 1998 Nov; 126(11):1330-7. PubMed ID: 10349176 [TBL] [Abstract][Full Text] [Related]
8. Sudomotor, skin vasomotor, and cardiovascular reflexes in 3 clinical forms of Lewy body disease. Akaogi Y; Asahina M; Yamanaka Y; Koyama Y; Hattori T Neurology; 2009 Jul; 73(1):59-65. PubMed ID: 19564585 [TBL] [Abstract][Full Text] [Related]
9. Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients. Jainkittivong A; Lin AL; Johnson DA; Langlais RP; Yeh CK Oral Dis; 2009 Apr; 15(3):229-34. PubMed ID: 19207880 [TBL] [Abstract][Full Text] [Related]
10. Impaired efficacy of cough in patients with Parkinson disease. Ebihara S; Saito H; Kanda A; Nakajoh M; Takahashi H; Arai H; Sasaki H Chest; 2003 Sep; 124(3):1009-15. PubMed ID: 12970031 [TBL] [Abstract][Full Text] [Related]
11. Variability of flow rate when collecting stimulated human parotid saliva. Burlage FR; Pijpe J; Coppes RP; Hemels ME; Meertens H; Canrinus A; Vissink A Eur J Oral Sci; 2005 Oct; 113(5):386-90. PubMed ID: 16202025 [TBL] [Abstract][Full Text] [Related]
12. Mortality of Parkinson's disease by Hoehn-Yahr stage from community-based and clinic series [Keelung Community-based Integrated Screening (KCIS) no. 17)]. Liou HH; Wu CY; Chiu YH; Yen AM; Chen RC; Chen TF; Chen CC; Hwang YC; Wen YR; Chen TH J Eval Clin Pract; 2009 Aug; 15(4):587-91. PubMed ID: 19674213 [TBL] [Abstract][Full Text] [Related]
13. Six-minute walk distance in persons with Parkinson disease: a hierarchical regression model. Falvo MJ; Earhart GM Arch Phys Med Rehabil; 2009 Jun; 90(6):1004-8. PubMed ID: 19480877 [TBL] [Abstract][Full Text] [Related]
14. Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication. DiFrancisco-Donoghue J; Elokda A; Lamberg EM; Bono N; Werner WG Mov Disord; 2009 Sep; 24(12):1773-8. PubMed ID: 19562762 [TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders]. Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293 [TBL] [Abstract][Full Text] [Related]
16. Significantly reduced salivary nitric oxide synthesis in patients with Parkinson's disease. Huskić J; Paperniku A; Husić A; Alendar F; Mulabegović N Bosn J Basic Med Sci; 2005 Aug; 5(3):86-9. PubMed ID: 16351589 [TBL] [Abstract][Full Text] [Related]